Letter to the Editor

Abstract

References

Hansson GK Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695.

Blasi C. The autoimmune origin of atherosclerosis. Atherosclerosis . 2008;201:17-32.

Tedgui A. , Mallat Z. Cytochines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev. 2006;86:515-581.

Stehbens WE Experimental induction of atherosclerosis associated with femoral arteriovenous fistulae in rabbits on a stock diet. Atherosclerosis. 1992;95:127-135.

Stehbens WE Histological changes in chronic experimental aneurysms surgically fashioned in sheep. Pathology. 1997;29:374-379.

Glueck CJ , Heckman F. , Schoenfeld M. , Steiner P. , Pearce W. Neonatal familial type II hyperlipoproteinemia: cord blood cholesterol in 1800 births. Metabolism. 1971;20:597-608.

Stehbens WE Coronary heart disease, hypercholesterolemia and atherosclerosis. I. False premises. Exp Mol Pathol. 2001;70:103-119.

Hulley SB , Newman TB Cholesterol in the elderly Is it important? . JAMA. 1994;272:1372-1373.

Cannon CP , Braunwald E. , McCabe CH , et al, for the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004 ;350:1495-1504.

10.

Steinberg D. , Glass CK , Witztum JL Evidence mandating earlier and more aggressive treatment of hypercholesterolemia. Circulation. 2008;118:672-677.

11.

Yakirevich E. , Resnick MB Regulatory T lymphocytes: pivotal components of the host antitumor response. J Clin Oncol. 2007;25:2506-2508.

12.

Alsheikh-Ali AA , Maddukuri PV , Han H. , Karas RH Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials. J Am Coll Cardiol. 2007;50:409-418.

13.

Alsheikh-Ali AA , Trikalinos TA , Kent DM , Karas RH Statins, low-density lipoprotein cholesterol, and risk of cancer. J Am Coll Cardiol. 2008 ;52:1141-1147.

14.

Shepherd J. , Blauw GJ , Murphy MB , et al, on behalf of the PROSPER study group. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360:1623-1630.

15.

Wenger NK , Lewis SJ , Welty FK , Herrington DM , Bittner V. , on behalf of the TNT Steering Committee and Investigators. Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Target (TNT) study. Heart. 2008;94:434-439.